Activities of taurolidine in vitro and in experimental enterococcal endocarditis

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 6, 2000, Pages 1720-1724

  Torres Viera, C ^a,b   Thauvin Eliopoulos, C ^a,b   Souli, M ^a,b   Degirolami, P ^a,b   Farris, M G ^a   Wennersten, C B ^a   Sofia, R D ^c   Eliopoulos, G M ^a,b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Wallace Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; CIPROFLOXACIN; IMIPENEM; OXACILLIN; TAUROLIDINE; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL ENDOCARDITIS; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DRUG EFFICACY; ENTEROCOCCUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; STAPHYLOCOCCUS; STENOTROPHOMONAS MALTOPHILIA;

ANIMALS; ANTI-BACTERIAL AGENTS; ENDOCARDITIS, BACTERIAL; OXACILLIN; PENICILLIN RESISTANCE; PENICILLINS; STAPHYLOCOCCUS; STENOTROPHOMONAS MALTOPHILIA; TAURINE; THIADIAZINES;

EID: 0034118234     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.6.1720-1724.2000     Document Type: Article

References (13)

1. Baker, D. M., J. A. Jones, J. S. Nguyen-Van-Tam, J. H. Lloyd, D. L. Morris, J. B. Bourke, R. J. Steele, and J. D. Hardcastle. 1994. Taurolidine peritoneal lavage as prophylaxis against infection after elective colorectal surgery. Br. J. Surg. 8:1054-1056.
2. Bedrosian, I., R. D. Sofia, S. M. Wolff, and C. A. Dinarello. 1991. Taurolidine, an analogue of the amino acid taurine, suppresses interleukin 1 and tumor necrosis factor synthesis in human peripheral blood mononuclear cells. Cytokine 3:568-575.
3. Blenkharn, J. I. 1990. In vitro antibacterial activity of noxythiolin and taurolidine. J. Pharm. Pharmacol. 42:589-590.
4. Browne, M. K., G. B. Leslie, and R. W. Pfirrmann. 1976. Taurolin, a new chemotherapeutic agent. J. Appl. Bacteriol. 41:363-368.
5. Gorman, S. P., D. F. McCafferty, A. D. Wolfson, and D. S. Jones. 1987 Reduced adherence of micro-organisms to human mucosal epithelial cells following treatment with taurolin, a novel antimicrobial agent. J. Appl. Bacteriol. 62:315-320.
6. Hindes, R. G., S. H. Willey, G. M. Eliopoulos, L. B. Rice, C. T. Eliopoulos, B. E. Murray, and R. C. Moellering, Jr. 1989. Treatment of experimental endocarditis caused by a β-lactamase-producing strain of Enterococcus faecalis with high-level resistance to gentamicin. Antimicrob. Agents Chemother. 33:1019-1022.
7. National Committee for Clinical Laboratory Standards. 1997. Methods for antimicrobial susceptibility testing of anaerobic bacteria. Approved standard. 4th ed. NCCLS document M11-A4. National Committee for Clinical Laboratory Standards, Wayne, Pa.
8. National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard, 4th ed. NCCLS document M7-A4. National Committee for Clinical Laboratory Standards, Wayne, Pa.
9. Nösner, K., and J. Focht. 1994. In-vitro-Wirksamkeit von Taurolidine und 9 Antibiotika gegen klinische Isolate aus chirurgischem Einsendegutsowie gegen Pilze. Chir. Gastroenterol. 10(Suppl. 2):80-89.
10. Schülin, T., C. Thauvin-Eliopoulos, R. C. Moellering, Jr., and G. M. Eliopoulos. 1999. Activities of the oxazolidinones linezolid and eperezolid in experimental intra-abdominal abscess due to Enterococcus faecalis or vancomycin-resistant Enterococcus faecium. Antimicrob. Agents Chemother. 43: 2873-2876.
11. Traub, W. H., B. Leonhard, and D. Bauer. 1993. Taurolidine: in vitro activity against multiple-antibiotic-resistant, nosocomially significant clinical isolates of Staphylococcus aureus, Enterococcus faecium, and diverse Enterobacteriaceae. Chemotherapy 39:322-330.
12. Willatts, S. M., S. Radford, and M. Leitermann. 1995. Effect of the antiendotoxic agent, taurolidine, in the treatment of sepsis syndrome: a placebo-combined, double-blind trial. Crit. Care Med. 23:1033-1039.
13. Zimmermann, M., and V. Preac-Mursic. 1992. In vitro activity of taurolidine, chlorophenol-camphor-menthol and chlorhexidine against oral pathogenic microorganisms. Drug Res. 42:1157-1159.